<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<title>article20</title>
<style>
        body {
            font-family: Arial, sans-serif;
            margin: 0;
            padding: 0;
            background-color: #f3f3f3;
        }
        .container {
            max-width: 800px;
            margin: auto;
            background: #fff;
            padding: 20px;
            box-shadow: 0 0 10px rgba(0, 0, 0, 0.1);
        }
        h1, h2 {
            color: #333;
        }
        p {
            line-height: 1.6;
        }
        a {
            text-decoration: none;
            color: #5a5a5a;
        }
        a:hover {
            color: #000;
        }
    </style>
</head>
<body>
<div class="container"><p><a href="../index.html">Back to Index</a></p><li><a href="https://www.wikijournalclub.org/wiki/TIMACS" style="display:block; margin-bottom:10px;">TIMACS Original</a></li>
<h2><strong>TIMACS</strong></h2>
<div class="container">
<h2><strong></strong></h2>
<div class="container">
<div class="container">
<h2><strong></strong></h2>
<h2><strong></strong></h2>

    "Early Versus Delayed Intervention in Acute Coronary Syndromes". The New England Journal of Medicine. 2009. 360(21):2165-2175. PubMed • Full text • PDF<br/>
<br/>
<h2><strong>Clinical Question</strong></h2><br/>
Does early intervention improve outcomes compared to delayed intervention in patients with acute coronary syndromes without ST-segment elevation?<br/>
<br/>
<h2><strong>Bottom Line</strong></h2><br/>
In patients with acute coronary syndromes without ST-segment elevation, early intervention did not significantly improve the primary outcome of death, myocardial infarction, or stroke compared to a delayed intervention, but it did reduce the rate of secondary outcomes such as refractory ischemia and was superior in high-risk patients.<br/>
<br/>
<h2><strong>Major Points</strong></h2><br/><br/>
<br/>
<h2><strong>Guidelines</strong></h2><br/>
Current guidelines recommend risk stratification for patients with acute coronary syndromes, suggesting that an invasive strategy is generally safe, and the decision between early or delayed intervention may be based on patient risk levels and facility availability.<br/>
<br/>
<h2><strong>Design</strong></h2><br/>
- Multicenter, randomized, parallel-group trial<br/>
- N=3,031 patients with acute coronary syndromes<br/>
- Early intervention (coronary angiography within 24 hours) vs. delayed intervention (coronary angiography after at least 36 hours)<br/>
- Mean follow-up: 6 months<br/>
<br/>
<h2><strong>Population</strong></h2><br/>
- Adults with unstable angina or myocardial infarction without ST-segment elevation and at least two of the following risk factors: age ≥60, elevated cardiac biomarkers, or ECG changes indicative of ischemia<br/>
<br/>
<h2><strong>Interventions</strong></h2><br/>
- Early intervention group underwent coronary angiography within 24 hours of randomization<br/>
- Delayed intervention group underwent coronary angiography after a minimum of 36 hours post-randomization<br/>
<br/>
<h2><strong>Outcomes</strong></h2><br/>
- Primary: Composite of death, myocardial infarction, or stroke at 6 months<br/>
- Secondary: Composite of death, myocardial infarction, or refractory ischemia at 6 months<br/>
- Other outcomes included the individual components of the primary and secondary outcomes<br/>
<br/>
<h2><strong>Criticisms</strong></h2><br/>
- The trial might have been underpowered to detect small differences in the primary outcome.<br/>
- The trial did not include a conservative-therapy group for comparison.<br/>
<br/>
<h2><strong>Funding</strong></h2><br/>
- Supported by the Canadian Institutes of Health Research, OASIS-5 study sponsors (including GlaxoSmithKline, Sanofi-Aventis, Organon NV), a New Investigator Award from the Canadian Institutes of Health Research, and the Heart and Stroke Foundation of Ontario.<br/>
<br/>
<h2><strong>Further Reading</strong></h2><br/><p></p>
</div>
</div>
</div>
</div>
</body>
</html>
